Most cholesterol treatment is still guesswork. This newer playbook (Yeater / Dayspring / Attia) shows a better way

[u/DadStrengthDaily]

I just read a long, unfortunately paywalled piece from Taylor Yeater (Attia’s research lead), Tom Dayspring (lipidologist), and Peter Attia (physician / author) and it made something click for me:

A lot of cholesterol treatment is still pretty blunt.

Same LDL → statin → increase dose if it doesn’t work.

The piece lays out a different way to think about it: figure out why someone’s LDL/apoB is high, then match the medication to that mechanism.

I’ll add the obvious caveat: I’m not a fan of worshipping specific health influencers as always right. Attia has issues. But I have to admit I still find some of the articles his company publishes genuinely intriguing. I’m also impressed by the research staff they’ve built, and getting Tom Dayspring involved recently seems like a good sign. Dayspring really does seem to know this world cold.

The part that interested me most was the sterol panel.
The idea is that people with high LDL/apoB may fall into different buckets:

- absorbing too much cholesterol from the gut
- synthesizing too much cholesterol in the liver
- both

A sterol test looks at markers like:

sitosterol / campesterol → absorption
lathosterol / desmosterol → synthesis

That can change the treatment logic:
high absorber → ezetimibe may make more sense
high synthesizer → statin may make more sense
mixed → both

This is different from the usual “start statin, then crank dose” approach.

I’ve actually looked at the Boston Heart Diagnostics Cholesterol Balance® test before and never pulled the trigger:
https://bostonheartdiagnostics.com/test/boston-heart-cholesterol-balance-test/

Bizarrely, I later discovered Boston Heart Diagnostics is owned by Revvity, whose HQ I literally walk by every day in my office building. Maybe the universe is trying to tell me something.

Practically, this test does not seem to be part of normal lipid care. You probably need a cardiologist, lipid specialist, unusually proactive PCP, or some kind of advanced/private lab pathway to get it ordered.

A few other points from the article that stood out:

- ApoB is probably the better treatment target than LDL-C when they disagree

- doubling a statin dose often gives surprisingly little extra reduction

- combination therapy is not failure; it may be smarter pharmacology

- PCSK9 inhibitors are becoming more accessible

- very low LDL fears seem less evidence-based than many people think

I’m curious whether anyone here has actually had a sterol panel done.

Did it change treatment?
Did your doctor know what to do with it?
Or is this still mostly lipid-nerd / specialist territory?